ESC Professional Premium Access

Cardiovascular epidemiology & trial design

Event: ESC Congress 2022
Topic: Cardiovascular Epidemiology
Session type: Abstract Sessions
Date: 27 August 2022
Time: 16:45 - 17:45

Congress Session

6 presentations in this session

Accuracy of event rate and effect size estimation in major cardiovascular trials

Speaker: Assistant Professor C. Olivier (Freiburg, DE)

Medication adherence assessment and reporting in cardiovascular randomised controlled trials

Speaker: Doctor Z. Ashkir (Oxford, GB)

AT-RISK: AuToimmune disorders and cardiovascular RISK.

Speaker: Doctor N. Conrad (Leuven, BE)

Long-term effects of coronavirus disease 2019 on the cardiovascular system: the CV COVID-19 registry

Speaker: Doctor V. Arevalos Rivas (Barcelona, ES)

The REALITY project: analysis of a national database with 1.8 million real-life patients to study atherosclerotic cardiovascular disease and familial hypercholesterolemia in Spain.

Speaker: Professor V. Barrios (Madrid, ES)

Development of a risk prediction score and equation for chronic kidney disease: A retrospective cohort study

Speaker: Doctor S. Kawasoe (Kagoshima, JP)

6 speakers from this session

Assistant Professor Christoph Olivier

University of Freiburg, Freiburg (Germany)
0 follower

Doctor Zakariye Ashkir

University of Oxford Centre for Clinical Magnetic Resonance Research, Oxford (United Kingdom of Great Britain & Northern Ireland)
0 follower

Doctor Nathalie Conrad

University of Leuven, Leuven (Belgium)
2 presentations
0 follower

Doctor Victor Andres Arevalos Rivas

Hospital Clinic of Barcelona, Barcelona (Spain)
0 follower

Professor Vivencio Barrios

Ramon and Cajal University Hospital, Madrid (Spain)
1 presentation
0 follower

Doctor Shin Kawasoe

Kagoshima University, Kagoshima (Japan)
0 follower

This platform is supported by

logo Novo Nordisk